---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-26-000024"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2026-03-10T23:59:59+00:00"
generated_at: "2026-05-15T15:31:00.632949+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Elevance Health reaffirms FY2026 adj. EPS at least $25.50, benefit expense ratio ~90.2%

## Summary
- Reaffirms adjusted shareholders' earnings for FY2026 at least $25.50 per diluted share.
- Reaffirms 2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points.
- Guidance includes impact of potential CMS sanctions suspending Medicare Advantage enrollment effective March 31, 2026 if not resolved.
- Company cannot provide GAAP reconciliation due to uncertainty over financial payments to resolve CMS matter.

## SEC filing metadata
- accession: 0001156039-26-000024
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2026-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000024/0001156039-26-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000024/elv-20260310.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-26-000024
- JSON: https://secwatch.observer/filing/0001156039-26-000024.json
- Plain text: https://secwatch.observer/filing/0001156039-26-000024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.